Salute e Benessere

Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune…

Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to help address root causes of ITP Approval based on LUNA 3 phase 3 study that demonstrated rapid and durable platelet response and improvements in other ITP symptomsITP is a disease of complex immune dysregulation leading to low platelet counts, bleeding, and reduced quality of life; more than 25,000 US adults could benefit from advanced...

FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection for…

LEQEMBI IQLIK is the first and only anti-amyloid treatment to offer an at-home injection to help patients and care partners continue to treat this progressive, relentless diseaseafter initial treatment of 18 monthsLEQEMBI IQLIK will be launched on October 6, 2025, in the U.S. TOKYO and CAMBRIDGE, Mass., Aug.29, 2025(GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO:...

Information on the total number of voting rights and shares

REGULATED INFORMATIONInformation on the total number of voting rights and sharesMont-Saint-Guibert(Belgium), August 29, 2025 , 10:30 pm CET / 4:30 pm ET –In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares. Share capital: EUR 6,449,871.98 Total number of securities carrying voting rights: 37,544,782 (all ordinary...

Smile Hair Clinic Becomes the First Hair Transplant Clinic in the World to…

Based in Germany, TEMOS operates in more than 20 countries and is known for its strict evaluations of hospitals and healthcare institutions. These inspections cover not only medical quality, but also patient and staff safety, ethical practices, sustainability, quality management, infrastructure, and service security. Based in Germany, TEMOS operates in more than 20 countries and is known for its strict evaluations of hospitals and healthcare institutions. These inspections cover not only...

Innocan Pharma Announces Details of Proposed Share Consolidation

Innocan has applied to list its Common Shares and Warrants on the Nasdaq Capital Market under the symbols "INNP" and "INNPW", respectively. Innocan has applied to list its Common Shares and Warrants on the Nasdaq Capital Market under the symbols "INNP" and "INNPW", respectively. ThinkEquity LLC is acting as representative underwriter in the offering. This proposed offering will be made only by means of a prospectus. Upon availability, copies of the…

IPSEN - Buy-back programme - Art 5 of MAR - Week 34 - 2025

Aggregated presentation by day and by marketStatement of transactions in own shares from August 18 thto August 22 nd2025Name of the issuerIdentity code of the issuer(Legal Entity Identifier) Day of the transactionIdentity code of the financial instrument Total daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code) IPSEN549300M6SGDPB4Z94P1118/08/2025FR0010259150 600113...

Portable Ultrasound Market worth US$3.84 billion by 2030 with 9.0% CAGR |…

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=114058057 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=114058057 Browse in-depth TOC on "Portable Ultrasound Market" 384 - Tables 45 - Figures 245 - Pages By product type,Transducers/probes are experiencing the highest CAGR in the portable ultrasound market because they are critical components that directly impact image quality and diagnostic accuracy,...

Pharmaceutical Contract Manufacturing Market worth US$311.95 billion by 2030…

Browse in-depth TOC on "Pharmaceutical Contract Manufacturing Market" Browse in-depth TOC on "Pharmaceutical Contract Manufacturing Market" 450 - Tables60 - Figures456 - Pages By service,the global pharmaceutical contract manufacturing market is segmented by service into drug development services, pharmaceutical manufacturing services, biologic manufacturing services, packaging & labelling services, fill-finish services, and other services. In 2024, the...

Embla Medical hf: Embla Medical closes the majority share investment in…

Reference is made to announcement no. 31/2025 published on 17 July 2025 (Embla Medical signs agreement to invest in a majority share in Streifeneder ortho.production GmbH). Reference is made to announcement no. 31/2025 published on17 July 2025(Embla Medical signs agreement to invest in a majority share in Streifeneder ortho.production GmbH). REYKJAVIK, Iceland and COPENHAGEN, Denmark, Aug. 29, 2025 /PRNewswire/ -- Embla Medical (NASDAQ Copenhagen: EMBLA), a leading global...

Seminar: IP That Matters - Behind Orexo's Milestone Patent Win at the US Court

Orexo has successfully developed four drugs from concept to market, including Zubsolv® for opioid dependence, which is commercialized by Orexo in the US. The company has extensive experience in building robust patent strategies that support product development cycles. Orexo has demonstrably and repeatedly benefited from these strategies, including when its innovations have been challenged by leading international generic companies, such as Actavis/Teva in 2018 and, more recently, Sun…

Morphy Richards Brings "Innovate for Enlightening Progress" to IFA Berlin 2025

Building on the success of the S1 Pro—the world's first ductless air conditioner, which raised about $1 million on Kickstarter and earned accolades at IFA 2024, Morphy Richards will debut the S1 Ultra at IFA 2025. Powered by Fusion Max Tech, the S1 Ultra offers five-in-one functionality, including cooling, heating, humidifying, airflow, and ductless operation, providing year-round comfort. Inspired by aircraft engines and accented with subtle wood elements, it combines advanced innovation with…

Vaccine Refrigerators Market Size to Reach US$ 2.50 Billion by 2033 with 7.6%…

In parallel, manufacturers such as Haier Biomedical, B Medical Systems, and Thermo Fisher Scientific Inc. are innovating with IoT-enabled monitoring, green refrigerants, and energy-efficient models, aligning with global sustainability goals while reducing vaccine wastage. As governments, NGOs, and private healthcare providers continue to strengthen cold chain systems, the market is expected to expand toward smarter, greener, and more resilient refrigeration solutions, ensuring that vaccines…

Gateway to Growth: Innovation and Opportunity at the 8th CIIE

At the supply-demand matchmaking event of the 8th CIIE, companies showcased 22 "CIIE Babies" —products that have successfully entered the market after their debut at previous expos, including two making their first post-launch appearance, underscoring the CIIE's role in turning exhibits into goods. Medical innovations have also gained ground in China. Novartis built on its RLT debut last year by partnering with GE Healthcare China and others to create an RLT ecosystem. Meanwhile…

Purepeak: Korean Anti-Aging Brand Chosen by European Pharmacies

Purepeak's signature "Beauty Solid Line" features concentrated, plant-derived ingredients in a solid stick formula that delivers hydration, nourishment, and anti-aging benefits in one. Infused with botanical extracts for deep skin nutrition and UV-blocking ingredients to protect against photoaging, the line goes beyond basic sun protection—positioning itself as part of a comprehensive anti-aging routine. This innovative approach aligns with the growing "skinimalism" trend…

New number of shares and votes in Sobi

Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK 26 billion. Sobi's share (STO:SOBI) is listed on Nasdaq Stockholm. Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with...

OSE Immunotherapeutics Reaffirms its Strategic Priorities and Publishes…

OSE Immunotherapeutics Reaffirms its Strategic Priorities and Publishes Shareholder Q&A to Restore Information Ahead of AGM Nantes, August 29, 2025, 8:00 a.m. CET -OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today published a comprehensive Questions and Answers document in advance of its Annual General Meeting (AGM) convened on September 30, 2025. The document provides clear, factual information about financing, governance, scientific development and the...

UCB presents latest research and clinical advancement across leading epilepsy…

Highlights of data to be presented at IEC: Highlights of data to be presented at IEC: Fenfluramine: A combined open-label extension (OLE) study enrolled 412 patients with DS or LGS who had participated in three previous fenfluramine studies, reporting no new or unexpected safety signals and long-term sustained benefit. [2] Barriers and benefits of identifying patients with DEEs in adult care settings: Although the diagnosis of DEEs in children has become routine,...

PCI Biotech half-year interim 2025 report

Highlights review OperationsPCI Biotech decided on 18th August 2025 to discontinue further development of the PCL technology. The decision was primarily based on, as described in a press release the same day, insufficient progress towards the 2025 goal of demonstrating improved net yield at mini benchtop bioreactor scale. Achieving successful results at this scale was a critical risk-reducing milestone for further development. Following the progress reported in the preliminary 2024...

Santhera Enters into Agreement with Ikris Pharma Network for the Distribution of…

Pratteln, Switzerland , 29 August , 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Ikris Pharma Network (Ikris) to manage the distribution of AGAMREE® (vamorolone) in India, for the treatment of Duchenne muscular dystrophy (DMD) in patients four years of age and older. The agreement between Santhera and Ikris has a 5-year term and Santhera will receive a percentage of net sales, in line with previous distribution agreements. Sales are...

PharmaResearch Establishes European Distribution Partnership for 'Rejuran'

VIVACY, headquartered in France, is one of the leading company's in the European medical aesthetics industry. With subsidiaries and branch offices across key cities in Europe, VIVACY has built a robust commercial and marketing network. VIVACY, headquartered inFrance, is one of the leading company's in the European medical aesthetics industry. With subsidiaries and branch offices across key cities inEurope, VIVACY has built a robust commercial and marketing network. Through this...

Global Pharmaceutical Contract Manufacturing Market to Surpass the USD 360…

Key Takeaways from the Pharmaceutical Contract Manufacturing Market Report Key Takeaways from the Pharmaceutical Contract Manufacturing Market Report To read more about the latest highlights related to the pharmaceutical contract manufacturing market, get a snapshot of the key highlights entailed in theGlobal Pharmaceutical Contract Manufacturing Market Report Key Factors Contributing to the Rise in Growth of the Pharmaceutical Contract Manufacturing Market Rising Demand...

GSK 3 Inhibitor Market Landscape Shows Promising Upswing as Growing Interest in…

GSK 3 Inhibitors Market Summary GSK 3 Inhibitors Market Summary Discover which indication is expected to grab the major GSK 3 inhibitors market share @ GSK 3 Inhibitors Market Report Key Factors Driving the Growth of GSK 3 Inhibitors Market Strong preclinical and expanding GSK 3 inhibitor clinical pipeline Recent years have seen a rise in novel chemotypes, patents, and translation from bench to early clinical testing, increasing the chance that one or more candidates will...

Safety Gloves Market to Reach USD 30,358.87 Million by 2032, growing at a CAGR…

Key Growth Determinants Key Growth Determinants Rising Workplace Safety Regulations Government bodies and international organizations are enforcing stricter occupational safety standards across industries. Regulations such as OSHA (Occupational Safety and Health Administration) guidelines in the U.S. and EU workplace safety directives mandate the use of protective gloves in high-risk environments. Compliance with these norms has made safety gloves essential in manufacturing,...

Piramal Pharma Solutions Supports George Medicines in Developing its New Drug…

WIDAPLIK carries a Boxed Warning for fetal toxicity and should be discontinued as soon as pregnancy is detected. Please see full Prescribing Information and Important Safety Information, including Boxed Warning for WIDAPLIK here. WIDAPLIK carries a Boxed Warning for fetal toxicity and should be discontinued as soon as pregnancy is detected. Please see full Prescribing Information and Important Safety Information, including Boxed Warning for WIDAPLIKhere. George Medicines and Piramal...

Altri Comunicati